Abstract:Background Osteoclast plays an important role in maintaining the balance between bone anabolism and bone catabolism. The abnormality of osteoclast is closely related to osteolytic bone diseases such as osteoporosis, rheumatoid arthritis and tumor bone metastasis. Purpose We aim to search for natural compound that may suppress osteoclast formation and function. Study design In this study, we assessed the impact of Dauricine (Dau) on the formation and function of osteoclasts in vitro , as well as its potential in preventing bone loss in an ovariectomy mouse model in vivo . Methods Multiple in vitro experiments were carried out, including osteoclastogenesis, podosomal belt formation, bone resorption assay, RNA-sequencing, real-time quantitative PCR, ROS level detection, surface plasmon resonance assay, luciferase assay, and western blot. To verify the effect in vivo , an ovariectomized mouse model (OVX model) was constructed, and bone parameters were measured using micro-CT and histology. Furthermore, metabolomics analysis was performed on blood serum samples from the OVX model. Results In vitro experiments demonstrated that Dau inhibits RANKL-induced osteoclastogenesis, podosomal belt formation, and bone resorption function. RNA-sequencing results revealed that Dau significantly suppresses genes related to osteoclasts. Functional enrichment analysis indicated that Dau's inhibition of osteoclasts may be associated with NF-κB signaling pathways and reactive oxygen metabolism pathways. Molecular docking, surface plasmon resonance assay, and western blot analysis further confirm ed that Dau inhibits RANKL-induced osteoclastogenesis by modulating the ROS/NF-κB/NFATc1 pathway. Moreover, administration of Dau to OVX-induced mice validated its efficacy in treating bone loss disease. Conclusion Dau prevents OVX-induced bone loss by inhibiting osteoclast activity and bone resorption, potentially offering a new approach for preventing and treating metabolic bone diseases such as osteoporosis. This study provides innovative insights into the inhibitory effects of Dau in an in vivo OVX model and elucidates the underlying mechanism.

Dauricine Attenuates Vascular Endothelial Inflammation Through Inhibiting NF-κB Pathway

Neferine suppresses vascular endothelial inflammation by inhibiting the NF-κB signaling pathway

Dauricine Negatively Regulates Lipopolysaccharide- or Cecal Ligation and Puncture-Induced Inflammatory Response Via NF-κB Inactivation

An alkaloid from Menispermum dauricum , dauricine mediates Ca 2+ influx and inhibits NF-κB pathway to protect chondrocytes from IL-1β-induced inflammation and catabolism

Inhibitory Effect of Dauricine on Inflammatory Process Following Focal Cerebral Ischemia/Reperfusion in Rats

Daurisoline alleviated experimental colitis in vivo and in vitro: Involvement of NF-κB and Wnt/β-Catenin pathway

Dauricine Induces Apoptosis, Inhibits Proliferation and Invasion Through Inhibiting NF‐κB Signaling Pathway in Colon Cancer Cells

Abstract A2: Dauricine Inhibits IGF-I-induced HIF-1α Protein Accumulation and VEGF Expression

Effect of Dauricine on platelet accumulation in the pulmonary circulation of rabbits

Dauricine attenuates ovariectomized-induced bone loss and RANKL-induced osteoclastogenesis via inhibiting ROS-mediated NF-κB and NFATc1 activity

Anti-inflammatory effects of danshen on human vascular endothelial cells in culture

The Saponin DT-13 Attenuates Tumor Necrosis Factor-Α-induced Vascular Inflammation Associated with Src/NF-кB/MAPK Pathway Modulation.

Dragon’s Blood Attenuates LPS-induced Intestinal Epithelial Barrier Dysfunction Via Upregulation of FAK-DOCK180-Rac1-WAVE2-Arp3 and Downregulation of TLR4/NF-κB Signaling Pathways

Edaravone Attenuated Particulate Matter-Induced Lung Inflammation by Inhibiting ROS-NF-κB Signaling Pathway.

Bioactivity-integrated UPLC/Q-TOF–MS of Danhong Injection to Identify NF-κB Inhibitors and Anti-Inflammatory Targets Based on Endothelial Cell Culture and Network Pharmacology

Dragon's blood attenuates LPS-induced intestinal epithelial barrier dysfunction via upregulation of FAK-DOCK180-Rac1-WAVE2-Arp3 and downregulation of TLR4/NF-κB signaling pathways

Regulation of Microglia-Activation-Mediated Neuroinflammation to Ameliorate Ischemia-Reperfusion Injury Via the STAT5-NF-κB Pathway in Ischemic Stroke

Protective Effects of Daviditin A Against Endothelial Damage Induced by Lysophosphatidylcholine

Dauricine Inhibits Redistribution of Platelet Membrane Glycoprotein Iv and Release of Intracellular Alpha-Granule Thrombospondin Induced by Thrombin

Amygdalin attenuates PM2.5-induced human umbilical vein endothelial cell injury via the TLR4/NF-κB and Bcl-2/Bax signaling pathways

Protective Effects of Total Saponins of Aralia elata (Miq.) on Endothelial Cell Injury Induced by TNF-α via Modulation of the PI3K/Akt and NF-κB Signalling Pathways